000 01126 a2200313 4500
005 20250515022346.0
264 0 _c20060419
008 200604s 0 0 eng d
022 _a0171-2004
024 7 _a10.1007/3-540-27661-0_22
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMüller-Wieland, D
245 0 0 _aCorrection of insulin resistance and the metabolic syndrome.
_h[electronic resource]
260 _bHandbook of experimental pharmacology
_c2005
300 _a591-617 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdipose Tissue
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aGene Expression Regulation
650 0 4 _aHumans
650 0 4 _aInsulin
_xpharmacology
650 0 4 _aInsulin Resistance
650 0 4 _aMetabolic Syndrome
_xdrug therapy
650 0 4 _aPhosphorylation
650 0 4 _aSterol Regulatory Element Binding Protein 1
_xantagonists & inhibitors
700 1 _aKotzka, J
773 0 _tHandbook of experimental pharmacology
_gno. 170
_gp. 591-617
856 4 0 _uhttps://doi.org/10.1007/3-540-27661-0_22
_zAvailable from publisher's website
999 _c16202612
_d16202612